National Pension Service Buys 14,830 Shares of Stryker Co. (NYSE:SYK)

National Pension Service increased its position in Stryker Co. (NYSE:SYK - Free Report) by 2.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 627,139 shares of the medical technology company's stock after purchasing an additional 14,830 shares during the quarter. National Pension Service owned 0.17% of Stryker worth $187,803,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Farmers & Merchants Trust Co of Chambersburg PA boosted its stake in Stryker by 203.3% during the 4th quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 91 shares of the medical technology company's stock valued at $27,000 after acquiring an additional 61 shares during the last quarter. Rogco LP bought a new position in Stryker during the 4th quarter valued at $30,000. HBC Financial Services PLLC bought a new position in Stryker during the 4th quarter valued at $37,000. Bourgeon Capital Management LLC bought a new position in Stryker during the 4th quarter valued at $37,000. Finally, Venturi Wealth Management LLC boosted its stake in Stryker by 97.1% during the 4th quarter. Venturi Wealth Management LLC now owns 136 shares of the medical technology company's stock valued at $41,000 after acquiring an additional 67 shares during the last quarter. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, CAO William E. Berry, Jr. sold 7,690 shares of Stryker stock in a transaction that occurred on Thursday, March 7th. The shares were sold at an average price of $358.48, for a total value of $2,756,711.20. Following the transaction, the chief accounting officer now owns 3,675 shares of the company's stock, valued at $1,317,414. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 5.50% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on SYK. Wells Fargo & Company raised their price target on shares of Stryker from $364.00 to $381.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 1st. StockNews.com upgraded shares of Stryker from a "hold" rating to a "buy" rating in a research report on Tuesday, January 23rd. Needham & Company LLC restated a "hold" rating on shares of Stryker in a research report on Wednesday, May 1st. Barclays raised their price target on shares of Stryker from $372.00 to $376.00 and gave the stock an "overweight" rating in a research report on Thursday, May 2nd. Finally, Roth Mkm increased their price objective on shares of Stryker from $348.00 to $405.00 and gave the stock a "buy" rating in a report on Wednesday, May 1st. Four investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, Stryker has an average rating of "Moderate Buy" and an average price target of $365.94.

Stryker Trading Up 0.5 %

Shares of SYK traded up $1.58 during midday trading on Thursday, hitting $330.86. The stock had a trading volume of 980,396 shares, compared to its average volume of 1,327,501. Stryker Co. has a fifty-two week low of $249.98 and a fifty-two week high of $361.41. The business has a 50-day simple moving average of $345.60 and a two-hundred day simple moving average of $318.91. The firm has a market cap of $126.04 billion, a P/E ratio of 37.77, a price-to-earnings-growth ratio of 2.54 and a beta of 0.91. The company has a current ratio of 1.71, a quick ratio of 0.99 and a debt-to-equity ratio of 0.56.

Stryker (NYSE:SYK - Get Free Report) last announced its earnings results on Tuesday, April 30th. The medical technology company reported $2.50 EPS for the quarter, topping the consensus estimate of $2.36 by $0.14. The company had revenue of $5.24 billion during the quarter, compared to analysts' expectations of $5.10 billion. Stryker had a net margin of 16.03% and a return on equity of 23.05%. The business's revenue for the quarter was up 9.7% on a year-over-year basis. During the same period last year, the company posted $2.14 earnings per share. As a group, equities analysts forecast that Stryker Co. will post 11.94 EPS for the current year.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.